Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
17.12
-0.08 (-0.47%)
Jun 8, 2026, 4:00 PM EDT - Market closed
AAPG Market Cap
AAPG has a market cap or net worth of $1.59 billion as of June 8, 2026. Its market cap has decreased by -18.24% in one year.
Market Cap
1.59B
Enterprise Value
1.52B
1-Year Change
-18.24%
Ranking
Category
Stock Price
$17.12
Market Cap Chart
Since the IPO on June 13, 2022, AAPG's market cap has increased from $554.36M to $1.59B, an increase of 186.53%. That is a compound annual growth rate of 30.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 1.64B | -33.80% |
| Dec 31, 2025 | 2.47B | 36.38% |
| Dec 31, 2024 | 1.81B | 82.20% |
| Dec 29, 2023 | 994.30M | 16.90% |
| Dec 30, 2022 | 850.58M | 53.44% |
| Jun 13, 2022 | 554.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AbCellera Biologics | 1.67B |
| Sarepta Therapeutics | 1.64B |
| Generate Biomedicines | 1.64B |
| Innoviva | 1.63B |
| Agios Pharmaceuticals | 1.63B |
| Nurix Therapeutics | 1.61B |
| Tyra Biosciences | 1.57B |
| Fortrea Holdings | 1.57B |